期刊
NEUROLOGICAL SCIENCES
卷 38, 期 4, 页码 659-665出版社
SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10072-017-2823-y
关键词
ALS; Flow-metabolism uncoupling; Glucose metabolism; F-18-FDG; C-11-FMZ; PET
资金
- Ministry of Health, Labour and Welfare of Japan
- [25293202]
- [15K09316]
- [15K15527]
- [15K21181]
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease. In ALS, both glucose consumption and neuronal intensity reportedly decrease in the cerebral motor cortex when measured by positron emission tomography (PET). In this study, we evaluated cervical spinal glucose metabolism, blood flow, and neuronal intensity of 10 ALS patients with upper extremity (U/E) atrophy both with F-18-2-fluoro-2-deoxy-d-glucose (F-18-FDG) PET and C-11-flumazenil (C-11-FMZ) PET. On the ipsilateral side of C5 and T1 levels, F-18-FDG uptake increased significantly (*p < 0.05), and was correlated with the rate of progression of the ALS FRS-R-U/E score (R = 0.645, *p = 0.041). Despite this hyperglucose metabolism, the C-11-FMZ PET study did not show a coupled increase of spinal blood flow even though neuronal intensity did not decrease. These results indicate a strong correlation between hyperglucose metabolism and ALS progression alongside the uncoupling of flow-metabolism. This mechanism, which could result in subsequent motor neuronal death, may be a potential therapeutic target for ALS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据